Management of patients with ARDS secondary to Covid-19 who develop fibrotic changes in the Intensive Care Unit
G. Bermudo Peloche (Barcelona, Spain), M. Molina (Barcelona, Spain), V. Vicens (Barcelona, Spain), M. Hernández (Barcelona, Spain), G. Suárez (Barcelona, Spain), P. Trias (Barcelona, Spain), J. Bordas (Barcelona, Spain), S. Santos (Barcelona, Spain), S. Bolivar (Barcelona, Spain), B. Del Rio (Barcelona, Spain), J. Sabater (Barcelona, Spain), X. Perez (Barcelona, Spain), R. Jodar (Barcelona, Spain), M. Fuset (Barcelona, Spain)
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Bermudo Peloche (Barcelona, Spain), M. Molina (Barcelona, Spain), V. Vicens (Barcelona, Spain), M. Hernández (Barcelona, Spain), G. Suárez (Barcelona, Spain), P. Trias (Barcelona, Spain), J. Bordas (Barcelona, Spain), S. Santos (Barcelona, Spain), S. Bolivar (Barcelona, Spain), B. Del Rio (Barcelona, Spain), J. Sabater (Barcelona, Spain), X. Perez (Barcelona, Spain), R. Jodar (Barcelona, Spain), M. Fuset (Barcelona, Spain). Management of patients with ARDS secondary to Covid-19 who develop fibrotic changes in the Intensive Care Unit. 2537
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: